Tagrisso

AstraZeneca Daily Pill Effectively Reduces Lung Cancer Deaths in Half, According to Large Clinical Trial

Medicine & Technology Jun 09, 2023

Deaths of lung cancer patients were reduced in half by a once-daily pill made by AstraZeneca. Read the article to find out more.

FDA Grants Approval To AstraZeneca's New Lung Cancer Pill

Nov 16, 2015

The Food and Drug Administration (FDA) recently approved a new lung cancer pill, called AZD9291 or Tagrisso, from AstraZeneca after its two-year clinical trial with promising results.

Tagrisso

AstraZeneca Daily Pill Effectively Reduces Lung Cancer Deaths in Half, According to Large Clinical Trial

FDA Grants Approval To AstraZeneca's New Lung Cancer Pill

Most Popular

How Technology Is Changing the Real Estate Industry?

Nikolay Karpenko Biography, Photo, Career, Accomplishments

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

The Role of AI in the Next Generation of Logistics: Insights from Tobias Waldhecker

China’s Tiangong Space Station to Expand Its Capabilities With New Modules

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission